EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $239,000 | -29.7% | 7,705 | -6.9% | 0.01% | -18.2% |
Q1 2022 | $340,000 | -5.6% | 8,280 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $360,000 | -15.9% | 8,280 | -3.2% | 0.01% | -38.9% |
Q3 2021 | $428,000 | -20.6% | 8,552 | 0.0% | 0.02% | -18.2% |
Q2 2021 | $539,000 | -37.8% | 8,552 | -8.3% | 0.02% | -42.1% |
Q1 2021 | $867,000 | +3.7% | 9,330 | 0.0% | 0.04% | 0.0% |
Q4 2020 | $836,000 | -25.9% | 9,330 | -14.5% | 0.04% | -34.5% |
Q3 2020 | $1,128,000 | +21.9% | 10,918 | -6.6% | 0.06% | +18.4% |
Q2 2020 | $925,000 | +16.9% | 11,692 | -14.5% | 0.05% | +2.1% |
Q1 2020 | $791,000 | +25.6% | 13,669 | +17.1% | 0.05% | +60.0% |
Q4 2019 | $630,000 | -4.4% | 11,677 | -7.4% | 0.03% | -11.8% |
Q3 2019 | $659,000 | +7.9% | 12,611 | -0.2% | 0.03% | +3.0% |
Q2 2019 | $611,000 | +772.9% | 12,642 | +806.9% | 0.03% | +725.0% |
Q1 2019 | $70,000 | +52.2% | 1,394 | +78.0% | 0.00% | +33.3% |
Q4 2018 | $46,000 | +7.0% | 783 | +19.4% | 0.00% | +50.0% |
Q3 2018 | $43,000 | – | 656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |